Treatment for Magnesium Sulfate Extravasation
For magnesium sulfate extravasation, immediately stop the infusion, leave the cannula in place to aspirate as much extravasated solution as possible, apply dry cold compresses for 20 minutes 3-4 times daily for 1-2 days, elevate the limb, and provide analgesia as needed 1.
Immediate Management Steps
The ESMO-EONS guidelines provide a clear algorithmic approach for peripheral line extravasation that applies to magnesium sulfate 1:
- Stop the infusion immediately but leave the cannula in place
- Attempt gentle aspiration through the existing cannula to remove as much extravasated solution as possible - document the volume removed
- Avoid manual pressure over the extravasated area
- Apply dry cold compresses for 20 minutes, 3-4 times daily for 1-2 days (avoid alcohol compresses)
- Elevate the affected limb
- Administer analgesia as necessary
Important Context About Magnesium Sulfate as a Vesicant
Recent research demonstrates that concentrated magnesium sulfate (12.3%) is classified as a vesicant capable of causing erythema, induration, and ulceration with markedly prolonged tissue damage 2. Lower concentrations (0.6% magnesium sulfate) showed minimal injury similar to saline, while intermediate concentrations caused varying degrees of tissue damage 2.
A 2025 case report documented significant vascular injury from magnesium sulfate extravasation, including pulsatile bleeding requiring tourniquet application and surgical vascular ligation 3. This highlights that magnesium sulfate, though not traditionally considered a high-risk vesicant like chemotherapy agents, can cause serious tissue and vascular damage.
What NOT to Do
Do not inject subcutaneous corticosteroids - retrospective data shows that up to 46% of patients receiving intralesional corticoids needed surgical debridement versus only 13% without corticoids, suggesting a deleterious effect 1.
Specific Antidotes
The ESMO-EONS guidelines do not recommend specific antidotes for magnesium sulfate extravasation [1-1]. The antidotes discussed (sodium thiosulfate for mechlorethamine, DMSO for anthracyclines, dexrazoxane for anthracyclines, hyaluronidase for vinca alkaloids) are specific to chemotherapy agents and not applicable to magnesium sulfate.
Interestingly, one case report described using wet packing with magnesium sulfate as treatment for potassium chloride extravasation 4, but this represents magnesium as a treatment modality rather than the extravasated agent itself.
Monitoring and Escalation
- Monitor closely for signs of tissue necrosis or pain lasting more than 10 days
- Surgical debridement is indicated for unresolved tissue necrosis or persistent pain beyond 10 days 1
- Document thoroughly: patient identification, date/time, drug extravasated, signs/symptoms, IV access description, extravasation area and approximate volume, management steps with timing 1
- Photographic documentation can be helpful for follow-up and decision-making 1
Critical Pitfalls to Avoid
- Failing to recognize concentrated magnesium sulfate as a potential vesicant - the concentration matters significantly
- Applying manual pressure to the extravasation site, which can worsen tissue damage
- Using corticosteroids, which have been associated with worse outcomes
- Delaying recognition in the prehospital setting - EMS personnel must be vigilant about IV catheter placement and monitoring 3
The key is early recognition, immediate cessation of infusion, conservative supportive measures with cold compresses and elevation, and close monitoring for progression to tissue necrosis requiring surgical intervention.